Literature DB >> 26137096

Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.

Xianli Chen1, Liguan Liu1, Xingnan Pan1.   

Abstract

Portal vein tumor thrombus (PVTT) in hepatocellular carcinoma (HCC) is a common entity. However, the prognosis of patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) is extremely poor. The current study reports a case of HCC with PVTT, including a description of the gross surgical pathology and discussion of the relevance of assessing the growth of the tumor thrombus to the outcome of this disease. This case suggests that destruction of the primary tumor and PVTT must be considered according to the growth characteristics and modality of PVTT. It also indicates that transcatheter arterial embolization may be a suitable strategy for palliative treatment of patients with advanced HCC with PVTT.

Entities:  

Keywords:  Portal vein tumor thrombus; hepatocellular carcinoma

Year:  2015        PMID: 26137096      PMCID: PMC4473513          DOI: 10.3892/ol.2015.3115

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  A new classification for hepatocellular carcinoma with portal vein tumor thrombus.

Authors:  Jie Shi; Eric C H Lai; Nan Li; Wei-Xing Guo; Jie Xue; Wan-Yee Lau; Meng-Chao Wu; Shu-Qun Cheng
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-01       Impact factor: 7.027

3.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Zai-De Wu; Zhi-Wei Zhang; Zhi-Yong Huang; Yi-Fa Chen; Bi-Xiang Zhang; Song-Qing He; Wan-Guang Zhang
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

Review 5.  Chemoembolization for hepatocellular carcinoma.

Authors:  Jordi Bruix; Margarita Sala; Josep M Llovet
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  Epidemiology, risk factors, and natural history of hepatocellular carcinoma.

Authors:  Giuseppe Montalto; Melchiorre Cervello; Lydia Giannitrapani; Fabio Dantona; Angela Terranova; Luigi A M Castagnetta
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

9.  Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Jiangguo Zhang; Fengyun Gong; Ling Li; Manzhi Zhao; Jianxin Song
Journal:  Oncol Lett       Date:  2014-02-20       Impact factor: 2.967

10.  Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis.

Authors:  Alessandro Federico; Michele Orditura; Gaetano Cotticelli; Ilario DE Sio; Marco Romano; Antonietta Gerarda Gravina; Marcello Dallio; Alessio Fabozzi; Fortunato Ciardiello; Carmela Loguercio; Ferdinando DE Vita
Journal:  Oncol Lett       Date:  2015-02-12       Impact factor: 2.967

View more
  2 in total

1.  Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma.

Authors:  Huiyong Wu; Wei Zhao; Jianbo Zhang; Jianjun Han; Shuguang Liu
Journal:  BMC Gastroenterol       Date:  2018-11-12       Impact factor: 3.067

Review 2.  Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.

Authors:  Shuqun Cheng; Jiamei Yang; Feng Shen; Weiping Zhou; Yi Wang; Wenming Cong; Guang Shun Yang; Hongyan Cheng; Heping Hu; Chunfang Gao; Jia Guo; Aijun Li; Yan Meng; Xiaoqing Jiang; Yefa Yang; Guojun Qian; Ming Luo; Bing Hu; Xiaobo Man; Baohua Zhang; Changqing Su; Feiguo Zhou; Nan Li; Jie Shi; Meng Wang; Yaxin Zheng; Weixing Guo; Juxian Sun; Hongyang Wang; Wan-Yee Lau; Meng-Chao Wu
Journal:  Oncotarget       Date:  2016-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.